ORACTIVE develops medications against modern lifestyle diseases for global markets, based on our innovative, versatile ORASMART platform technology and proven APIs. Tolerability, convenience and medication comfort are our core elements for patient adherence and ultimate success of oral therapies.
Cooperation possibilities
Pipeline development, product distribution, fund-raising.
- https://www.oractive.ch
- Send an email
- Georg Toelkhaus, CFA
Some insights
We facilitate success of therapies and patient outcomes through better and more patient-friendly products. Thus contributing to a healthy and happy lifespan of people.
We and our extended network are extremely focused on applying underutilized technologies to improve therapies for existing molecules. We are constantly seeking for advice on target identification of new – old molecules with specific shortcomings to be mastered by our platform technology.
We marry technology and chemistry into creative products at an affordable price that make a real difference to patients.
Maintain and gain industry visibility.
Pharma (both innovative and premium segment generic) seeking to extend their portfolio or rejuvenate existing products. Investors who are interested in supporting our approach and ambitions.